Inventor
GEORGES GUY
DE72 patents
⚠️ This page may combine multiple inventors who share the name “GEORGES GUY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
39 patentsUS10323089B2Jun 18, 2019
Anti-transferrin receptor antibodies with tailored affinity
HOFFMANN LA ROCHE25 citations94
US9708396B2Jul 18, 2017
Bispecific anti-VEGF/anti-ANG-2 antibodies
HOFFMANN LA ROCHE16 citations92
US6531472B2Mar 11, 2003
Tetralone derivatives
HOFFMANN LA ROCHE23 citations92
US10501521B2Dec 10, 2019
Disulfide-linked multivalent MHC class I comprising multi-function proteins
HOFFMANN LA ROCHE39 citations91
US7462639B2Dec 9, 2008
Aminopyrazole derivatives
HOFFMANN LA ROCHE46 citations91
US11584793B2Feb 21, 2023
Anti-transferrin receptor antibodies with tailored affinity
HOFFMANN LA ROCHE8 citations85
US11286300B2Mar 29, 2022
Humanized anti-human CD19 antibodies and methods of use
HOFFMANN LA ROCHE11 citations85
US10287358B2May 14, 2019
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE3 citations84
US10072087B2Sep 11, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US7572809B2Aug 11, 2009
Isoquinoline aminopyrazole derivatives
HOFFMANN LA ROCHE11 citations84
US10822402B2Nov 3, 2020
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9862763B2Jan 9, 2018
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9765153B2Sep 19, 2017
Anti-biotin antibodies and methods of use
HOFFMANN LA ROCHE7 citations83
US9725512B2Aug 8, 2017
HER3 antibodies binding to the beta-hairpin of HER3
HOFFMANN LA ROCHE5 citations83
US9309319B2Apr 12, 2016
Antibodies against human IL33R and uses thereof
HOFFMANN LA ROCHE8 citations83
US11608376B2Mar 21, 2023
Tumor-targeted agonistic CD28 antigen binding molecules
HOFFMANN LA ROCHE14 citations82
US12252533B2Mar 18, 2025
Anti-transferrin receptor antibodies with tailored affinity
HOFFMANN LA ROCHE1 citations74
US11273223B2Mar 15, 2022
Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
HOFFMANN LA ROCHE1 citations73
US10806795B2Oct 20, 2020
Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
HOFFMANN LA ROCHE3 citations73
US10561737B2Feb 18, 2020
Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
HOFFMANN LA ROCHE4 citations73
US9925272B2Mar 27, 2018
Anti-theophylline antibodies and methods of use
HOFFMANN LA ROCHE3 citations73
US6800638B2Oct 5, 2004
Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
HOFFMANN LA ROCHE10 citations73
US10584178B2Mar 10, 2020
Bispecific HER2 antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US10538585B2Jan 21, 2020
Anti-ANG2 antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US10517945B2Dec 31, 2019
Covalently linked antigen-antibody conjugates
HOFFMANN LA ROCHE3 citations72
US10465000B2Nov 5, 2019
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US9562091B2Feb 7, 2017
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations72
US10730938B2Aug 4, 2020
Bispecific antibodies and methods of use in ophthalmology
HOFFMANN LA ROCHE3 citations71
US10344085B2Jul 9, 2019
Anti-IL-1beta antibodies
HOFFMANN LA ROCHE5 citations71
US10087246B2Oct 2, 2018
Anti-PDGF-B antibodies and methods of use
HOFFMANN LA ROCHE2 citations71
US10407511B2Sep 10, 2019
Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
HOFFMANN LA ROCHE2 citations70
US7226923B2Jun 5, 2007
Phthalazinone derivatives
HOFFMANN LA ROCHE8 citations70
US12297263B2May 13, 2025
Humanized anti-Tau(PS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US12215152B2Feb 4, 2025
Humanized anti-human CD19 antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US11827711B2Nov 28, 2023
Antibodies binding to NKG2D
HOFFMANN LA ROCHE1 citations62
US11572404B2Feb 7, 2023
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US7235574B2Jun 26, 2007
Pentafluorosulfanyl compounds
HOFFMANN LA ROCHE6 citations62
US7091229B2Aug 15, 2006
Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
HOFFMANN LA ROCHE4 citations62
US12227594B2Feb 18, 2025
Bispecific 2+1 contorsbodies
HOFFMANN LA ROCHE1 citations61
ROCHE GLYCART AG
4 patentsUS9926379B2Mar 27, 2018
Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5
ROCHE GLYCART AG17 citations92
US11214622B2Jan 4, 2022
Antibodies specific for DR5 and methods of use
ROCHE GLYCART AG6 citations83
US9346886B2May 24, 2016
Humanized anti-CDCP1 antibodies
ROCHE GLYCART AG8 citations83
US9611331B2Apr 4, 2017
Anti-HER3 antibodies and uses thereof
ROCHE GLYCART AG1 citations62
BAEHNER MONIKA
2 patentsROCHE PALO ALTO LLC
1 patentUS HEALTH
1 patentBRINKMANN ULRICH
1 patentAUER JOHANNES
1 patentBRAMLAGE BIRGIT
1 patentShowing the top 50 of 72 patents by PatentIndex Score.